Showing 21 - 40 results of 40 for search '"renal cancer"', query time: 0.07s Refine Results
  1. 21

    A Complex Cardiac Mass Originating from Interatrial Septum in a Patient with History of Kidney Cancer: A Case Report and Literature Review by Negar Faramarzi, Sumit Sohal, Roshanak Habibi, Muhammad Sikander Akbar

    Published 2018-01-01
    “…Transitional cell carcinomas are another form of renal cancer, which may metastasize to the heart and are associated with widespread metastasis. …”
    Get full text
    Article
  2. 22

    Adult onset wilms tumor by Madhangi Parameswaran, MBBS, Alison M. Friedmann, MD, Gregory M. Cote, MD, PhD, Keyan Salari, MD, PhD, Mukesh G. Harisinghani, MD, Rory L. Cochran, MD, PhD

    Published 2025-03-01
    “…The clinical presentation and imaging features of WT in adults are nonspecific and overlap with other more common forms of renal cancer, often leading to a delay in diagnosis. …”
    Get full text
    Article
  3. 23

    Solitary Contralateral Adrenal Metastases after Nephrectomy for Renal Cell Carcinoma by Nikolaos Antoniou, Demetrios Karanastasis

    Published 2004-01-01
    “…Adrenal involvement has been reported in 7 to 19% of autopsystudies. 1,3 Solitary metachronous metastatic involvement of the contralateral adrenal from renal cell carcinoma is rarely diagnosed during life and only 4 cases have been reported. 4,5 Recent advances in imaging techniques have allowed the diagnosis of adrenal involvement by renal cancer. Two cases of contralateral adrenal metastasis are reported 1 and 9 years after radical nephrectomy for localized renal cell carcinoma. …”
    Get full text
    Article
  4. 24

    Bilateral Renal Tumour as Indicator for Birt-Hogg-Dubé Syndrome by P. C. Johannesma, R. J. A. van Moorselaar, S. Horenblas, L. E. van der Kolk, E. Thunnissen, J. H. T. M. van Waesberghe, F. H. Menko, P. E. Postmus

    Published 2014-01-01
    “…In this case we describe a patient with bilateral renal tumour and a positive familial history for pneumothorax and renal cancer. Based on this clinical presentation, the patient was suspected for BHD syndrome, which was confirmed after molecular testing. …”
    Get full text
    Article
  5. 25

    Rapid Growth of Lung Nodules due to Combined Pulmonary Vasculitis, Silicoanthracosis, and Chondrocalcinosis by Wolfgang Jungraithmayr, Stefanos Tzafos, Oliver Distler, Antonios G. A. Kolios, Walter Weder, Daniel Franzen

    Published 2016-01-01
    “…We present the case of a 62-year old former pit worker with pulmonary nodules, chondrocalcinosis due to calcium pyrophosphate deposition (CPPD), and a history of renal cancer. Within a short period of time, pulmonary nodules grew rapidly. …”
    Get full text
    Article
  6. 26

    Nivolumab and Ipilimumab Combination Immunotherapy for Patients with Metastatic Collecting Duct Carcinoma by Tetsuya Danno, Shohei Iwata, Fusako Niimi, Sachi Honda, Haruka Okada, Takeshi Azuma

    Published 2021-01-01
    “…Collecting duct carcinoma (CDC) is a rare, extremely aggressive form of renal cancer. Recently, immune checkpoint inhibitors (ICI), anti-programmed death-1 (PD-1) antibody, and anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) antibody were approved for use against metastatic renal cell carcinoma. …”
    Get full text
    Article
  7. 27

    Endoscopic Retroperitoneal Adrenalectomy for Adrenal Metastases by Gintaras Simutis, Givi Lengvenis, Virgilijus Beiša, Kęstutis Strupas

    Published 2014-01-01
    “…A retrospective study was conducted, and clinical data, tumor characteristics, and oncologic outcomes were acquired and analyzed. Results. Renal cancer was the primary site of malignancy in 44.4% of cases. …”
    Get full text
    Article
  8. 28

    MicroRNA-4735-3p Facilitates Ferroptosis in Clear Cell Renal Cell Carcinoma by Targeting SLC40A1 by Cairong Zhu, Zhiquan Song, Zhen Chen, Tianqi Lin, Haili Lin, Zhenqiang Xu, Fen Ai, Shijiao Zheng

    Published 2022-01-01
    “…Clear cell renal cell carcinoma (ccRCC) is the major histopathological subtype of renal cancer, and ferroptosis is implicated in the pathogenesis of ccRCC. …”
    Get full text
    Article
  9. 29

    A clinical study of minimal blood flow clamping combined with 3D printing technology in laparoscopic nephron-sparing surgery by Lingbo Yang, Pengtao Wei, Xiaohui Li, Jiantao Sun

    Published 2025-01-01
    “…ObjectiveTo compare the safety and effectiveness of minimum flow clamping combined with 3D printing technology and highly selective renal artery clamping in laparoscopic nephron-sparing surgery.MethodsFifty-two patients with renal cancer undergoing partial resection admitted to Luoyang Central Hospital Affiliated with Zhengzhou University from 2018-01 to 2021-12 were randomly divided into two groups. …”
    Get full text
    Article
  10. 30

    Risk of second primary malignancies among survivors of cutaneous melanoma: A nationwide population-based study in the Republic of Korea by Joon Min Jung, Do Hyung Kim, Ye-Jee Kim, Ik Jun Moon, Woo Jin Lee, Sung Eun Chang, Mi Woo Lee, Chong Hyun Won

    Published 2025-01-01
    “…Additionally, specific SPMs were more common among melanoma survivors, including nonmelanoma skin cancer, oral cavity and pharyngeal cancer, renal cancer, female breast cancer, lung cancer, pancreatic cancer, and liver cancer. …”
    Get full text
    Article
  11. 31

    Synthesis, Characterization, Anticancer, and Antioxidant Studies of Ru(III) Complexes of Monobasic Tridentate Schiff Bases by Ikechukwu P. Ejidike, Peter A. Ajibade

    Published 2016-01-01
    “…In vitro anticancer studies of the synthesized complexes against renal cancer cells (TK-10), melanoma cancer cells (UACC-62), and breast cancer cells (MCF-7) was investigated using the Sulforhodamine B assay. …”
    Get full text
    Article
  12. 32

    RenalSegNet: automated segmentation of renal tumor, veins, and arteries in contrast-enhanced CT scans by Rashid Khan, Chao Chen, Asim Zaman, Jiayi Wu, Haixing Mai, Liyilei Su, Yan Kang, Bingding Huang

    Published 2025-01-01
    “…RenalSegNet's robust performance highlights its potential for clinical applications and offers significant advances in renal cancer treatment by contributing to accurate preoperative planning and postoperative evaluation. …”
    Get full text
    Article
  13. 33
  14. 34

    Expanding the miRNA Transcriptome of Human Kidney and Renal Cell Carcinoma by Adam P. Sage, Brenda C. Minatel, Erin A. Marshall, Victor D. Martinez, Greg L. Stewart, Katey S. S. Enfield, Wan L. Lam

    Published 2018-01-01
    “…We find that these novel kidney miRNAs are also expressed in renal cancer cell lines. Moreover, these sequences are differentially expressed between ccRCC and matched nonmalignant tissues, implicating their involvement in ccRCC biology and potential utility as tumour-specific markers of disease. …”
    Get full text
    Article
  15. 35

    Synthesis of bioactive quinazolin-4(3H)-one derivatives via microwave activation tailored by phase-transfer catalysis by El-Badry Yaser A., El-Hashash Mahr A., Al-Ali Khalil

    Published 2020-06-01
    “…The screened compounds exhibited a significant antitumor activity on some of the cancer cell lines, melanoma (SK-MEL-2), ovarian cancer (IGROV1), renal cancer (TK-10), prostate cancer (PC-3), breast cancer (MCF7) and colon cancer (HT29). …”
    Get full text
    Article
  16. 36

    PTEN suppresses renal cell carcinoma proliferation and migration via inhibition of the PI3K/AKT pathway by Xu Xu, Yuan-Yue Tang, Xiaohong Liang, Wen Luo, Dong-Mei Jiang, Jie Chen

    Published 2025-02-01
    “…Methods This study collected renal cancer and adjacent non-cancerous tissue samples from our hospital. …”
    Get full text
    Article
  17. 37

    Dimethyl fumarate promotes the degradation of HNF1B and suppresses the progression of clear cell renal cell carcinoma by Yue Dai, Hongchen Li, Shiyin Fan, Kai Wang, Ziyi Cui, Xinyu Zhao, Xue Sun, Mingen Lin, Jiaxi Li, Yi Gao, Ziyin Tian, Hui Yang, Bingbing Zha, Lei Lv, Yanping Xu

    Published 2025-02-01
    “…Abstract Clear cell renal cell carcinoma (ccRCC) is the most lethal subtype of renal cancer, and its treatment options remain limited. …”
    Get full text
    Article
  18. 38

    The cryptic lncRNA-encoded microprotein TPM3P9 drives oncogenic RNA splicing and tumorigenesis by Kun Meng, Yuying Li, Xiaoyi Yuan, Hui-Min Shen, Li-Ling Hu, Danya Liu, Fujin Shi, Dandan Zheng, Xinyu Shi, Nengqiao Wen, Yun Cao, Yun-Long Pan, Qing-Yu He, Chris Zhiyi Zhang

    Published 2025-01-01
    “…Collectively, our findings functionally and clinically characterize the “noncoding RNA”-derived microprotein TPM3P9 and thus identify potential prognostic and therapeutic factors in renal cancer.…”
    Get full text
    Article
  19. 39

    Parotid Oncocytoma as a Manifestation of Birt-Hogg-Dubé Syndrome by Kazuki Yoshida, Masao Miyagawa, Teruhito Kido, Kana Ide, Yoshifumi Sano, Yoshifumi Sugawara, Hiroyuki Takahata, Nobuya Monden, Mitsuko Furuya, Teruhito Mochizuki

    Published 2018-01-01
    “…Birt-Hogg-Dubé syndrome (BHD) is a rare autosomal dominant disease characterized by skin fibrofolliculomas, pulmonary cysts, spontaneous pneumothoraces, and renal cancers. Oncocytomas are benign epithelial tumors that are also rare. …”
    Get full text
    Article
  20. 40

    Transcriptome analysis of novel B16 melanoma metastatic variants generated by serial intracarotid artery injection by Jenny C. Kienzler, Erick M. Contreras, Janet Treger, Linda M. Liau, Geoffrey C. Owens, Robert M. Prins

    Published 2025-01-01
    “…Abstract The incidence of brain metastases (BrM) in patients with metastatic melanoma is reported to be 30–50% and constitutes the third most frequent BrM after breast and renal cancers. Treatment strategies including surgical resection, stereotactic radiation, and immunotherapy have improved clinical response rates and overall survival, but the changes that occur in circulating melanoma cells to promote invasion of the brain are not fully understood. …”
    Get full text
    Article